Sequent Scientific Limited

NSEI:SEQUENT Stok Raporu

Piyasa değeri: ₹49.4b

Sequent Scientific Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Sequent Scientific şirketinin toplam hissedar öz sermayesi ₹7.4B ve toplam borcu ₹4.5B olup, bu da borç-öz sermaye oranını 60.9% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ₹15.6B ve ₹8.2B dir. Sequent Scientific 'in FAVÖK'ü ₹867.4M faiz karşılama oranı 1.6 dur. Şirketin ₹742.6M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

60.9%

Borç/özkaynak oranı

₹4.52b

Borç

Faiz karşılama oranı1.6x
Nakit₹742.60m
Eşitlik₹7.42b
Toplam yükümlülükler₹8.20b
Toplam varlıklar₹15.62b

Son finansal sağlık güncellemeleri

Recent updates

We Think Sequent Scientific (NSE:SEQUENT) Is Taking Some Risk With Its Debt

Sep 27
We Think Sequent Scientific (NSE:SEQUENT) Is Taking Some Risk With Its Debt

What Sequent Scientific Limited's (NSE:SEQUENT) 32% Share Price Gain Is Not Telling You

Sep 05
What Sequent Scientific Limited's (NSE:SEQUENT) 32% Share Price Gain Is Not Telling You

Revenues Not Telling The Story For Sequent Scientific Limited (NSE:SEQUENT)

Apr 05
Revenues Not Telling The Story For Sequent Scientific Limited (NSE:SEQUENT)

Sequent Scientific (NSE:SEQUENT) Has A Somewhat Strained Balance Sheet

Mar 10
Sequent Scientific (NSE:SEQUENT) Has A Somewhat Strained Balance Sheet

Is Sequent Scientific's (NSE:SEQUENT) 177% Share Price Increase Well Justified?

Jan 31
Is Sequent Scientific's (NSE:SEQUENT) 177% Share Price Increase Well Justified?

How Much Did Sequent Scientific's (NSE:SEQUENT) CEO Pocket Last Year?

Jan 17
How Much Did Sequent Scientific's (NSE:SEQUENT) CEO Pocket Last Year?

Sequent Scientific Limited's (NSE:SEQUENT) Stock Is Going Strong: Have Financials A Role To Play?

Jan 05
Sequent Scientific Limited's (NSE:SEQUENT) Stock Is Going Strong: Have Financials A Role To Play?

What Kind Of Investors Own Most Of Sequent Scientific Limited (NSE:SEQUENT)?

Dec 24
What Kind Of Investors Own Most Of Sequent Scientific Limited (NSE:SEQUENT)?

Have Sequent Scientific Limited (NSE:SEQUENT) Insiders Been Selling Their Stock?

Dec 12
Have Sequent Scientific Limited (NSE:SEQUENT) Insiders Been Selling Their Stock?

Sequent Scientific (NSE:SEQUENT) Seems To Use Debt Rather Sparingly

Nov 22
Sequent Scientific (NSE:SEQUENT) Seems To Use Debt Rather Sparingly

Estimating The Intrinsic Value Of Sequent Scientific Limited (NSE:SEQUENT)

Nov 10
Estimating The Intrinsic Value Of Sequent Scientific Limited (NSE:SEQUENT)

The Sequent Scientific (NSE:SEQUENT) Share Price Is Up 102% And Shareholders Are Boasting About It

Oct 20
The Sequent Scientific (NSE:SEQUENT) Share Price Is Up 102% And Shareholders Are Boasting About It

How Does Sequent Scientific's (NSE:SEQUENT) CEO Pay Compare With Company Performance?

Oct 05
How Does Sequent Scientific's (NSE:SEQUENT) CEO Pay Compare With Company Performance?

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: SEQUENT 'nin kısa vadeli varlıkları ( ₹8.3B ) kısa vadeli yükümlülüklerini ( ₹4.9B ) aşıyor.

Uzun Vadeli Yükümlülükler: SEQUENT şirketinin kısa vadeli varlıkları ( ₹8.3B ) uzun vadeli yükümlülüklerini ( ₹3.3B ) aşmaktadır.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: SEQUENT 'nin net borç/öz sermaye oranı ( 50.9% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: SEQUENT şirketinin borç/öz sermaye oranı son 5 yılda 43.1% seviyesinden 60.9% seviyesine yükseldi.

Borç Kapsamı: SEQUENT 'nin borcu işletme nakit akışı ( 4.6% ) tarafından iyi bir şekilde karşılanmıyor.

Faiz Kapsamı: SEQUENT 'in borcuna ilişkin faiz ödemeleri EBIT ( 1.6 x kapsam) tarafından iyi karşılanmıyor.


Bilanço


Sağlıklı şirketleri keşfedin